BioCardia annual gross margin
2011
2015
2016
2017
2018
2019
2020
2021
BioCardia's gross margin was 100.00% for fiscal 2021.
View full BioCardia company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | 100.00% | +2.76 pp |
| 2020 | 2020-12-31 | 97.24% | +47.66 pp |
| 2019 | 2019-12-31 | 49.58% | +32.30 pp |
| 2018 | 2018-12-31 | 17.28% | +61.33 pp |
| 2017 | 2017-12-31 | −44.05% | −14.54 pp |
| 2016 | 2016-12-31 | −29.51% | −12.15 pp |
| 2015 | 2015-12-31 | −17.37% | — |
| 2011 | 2011-12-31 | 100.00% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2021 | 2021-09-30 | 100.00% | 0.00 pp |
| Q2 2021 | 2021-06-30 | 100.00% | 0.00 pp |
| Q4 2020 | 2020-12-31 | 100.00% | +17.29 pp |
| Q3 2020 | 2020-09-30 | 100.00% | +12.37 pp |
| Q2 2020 | 2020-06-30 | 100.00% | +222.09 pp |
| Q1 2020 | 2020-03-31 | 89.47% | +38.55 pp |
| Q4 2019 | 2019-12-31 | 82.71% | +95.33 pp |
| Q3 2019 | 2019-09-30 | 87.63% | +117.39 pp |
| Q2 2019 | 2019-06-30 | −122.09% | −165.61 pp |
| Q1 2019 | 2019-03-31 | 50.93% | +29.82 pp |
| Q4 2018 | 2018-12-31 | −12.62% | +52.38 pp |
| Q3 2018 | 2018-09-30 | −29.76% | −16.68 pp |
| Q2 2018 | 2018-06-30 | 43.51% | +124.76 pp |
| Q1 2018 | 2018-03-31 | 21.11% | +48.84 pp |
| Q4 2017 | 2017-12-31 | −65.00% | −42.37 pp |
| Q3 2017 | 2017-09-30 | −13.08% | +54.44 pp |
| Q2 2017 | 2017-06-30 | −81.25% | −72.92 pp |
| Q1 2017 | 2017-03-31 | −27.74% | −0.77 pp |
| Q4 2016 | 2016-12-31 | −22.63% | — |
| Q3 2016 | 2016-09-30 | −67.52% | — |
| Q2 2016 | 2016-06-30 | −8.33% | — |
| Q1 2016 | 2016-03-31 | −26.97% | — |
| Q3 2012 | 2012-09-30 | 100.00% | — |
| Q2 2012 | 2012-06-30 | 100.00% | — |
| Q1 2012 | 2012-03-31 | 100.00% | — |
| Q4 2011 | 2011-12-31 | 100.00% | — |
Over the last five fiscal years, BioCardia's gross margin increased from −29.51% to 100.00%, a change of +129.51 percentage points. The latest reported quarter, Q3 2021, shows 100.00%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioCardia source filings ↗